BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27001487)

  • 1. Detection of a specific pattern of hyaluronan oligosaccharides and their binding proteins in human ovarian tumour.
    Kolapalli SP; Nunna V; Thomas A; Mortha KK; Banerjee SD; Boregowda RK
    Cell Biochem Funct; 2016 Jun; 34(4):217-25. PubMed ID: 27001487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
    Matou-Nasri S; Gaffney J; Kumar S; Slevin M
    Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of ovarian cancer cells to immobilized hyaluronic acid.
    Catterall JB; Gardner MJ; Jones LM; Turner GA
    Glycoconj J; 1997 Nov; 14(7):867-9. PubMed ID: 9511993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
    Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
    Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis.
    Gardner MJ; Catterall JB; Jones LM; Turner GA
    Clin Exp Metastasis; 1996 Sep; 14(4):325-34. PubMed ID: 8878406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of ovarian cancer cells to immobilized hyaluronic acid.
    Catterall JB; Gardner MJ; Jones LM; Turner GA
    Glycoconj J; 1997 Aug; 14(5):647-9. PubMed ID: 9298699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 mediates oligosaccharides of hyaluronan-induced proliferation, tube formation and signal transduction in endothelial cells.
    Wang YZ; Cao ML; Liu YW; He YQ; Yang CX; Gao F
    Exp Biol Med (Maywood); 2011 Jan; 236(1):84-90. PubMed ID: 21239738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and syntheses of hyaluronan oligosaccharide conjugates as inhibitors of CD44-Hyaluronan binding.
    Lu X; Huang X
    Glycoconj J; 2015 Oct; 32(7):549-56. PubMed ID: 25997408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualisation of hyaluronan and hyaluronan-binding proteins within ovine vertebral cartilages using biotinylated aggrecan G1-link complex and biotinylated hyaluronan oligosaccharides.
    Melrose J; Tammi M; Smith S
    Histochem Cell Biol; 2002 Apr; 117(4):327-33. PubMed ID: 11976905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44.
    Cao JJ; Singleton PA; Majumdar S; Boudignon B; Burghardt A; Kurimoto P; Wronski TJ; Bourguignon LY; Halloran BP
    J Bone Miner Res; 2005 Jan; 20(1):30-40. PubMed ID: 15619667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer.
    Ricciardelli C; Ween MP; Lokman NA; Tan IA; Pyragius CE; Oehler MK
    BMC Cancer; 2013 Oct; 13():476. PubMed ID: 24124770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan.
    Catterall JB; Jones LM; Turner GA
    Clin Exp Metastasis; 1999; 17(7):583-91. PubMed ID: 10845557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive hyaluronan fragment (hexasaccharide) detects specific hexa-binding proteins in human breast and stomach cancer: possible role in tumorogenesis.
    Srinivas P; Kollapalli SP; Thomas A; Mortha KK; Banerjee SD
    Indian J Biochem Biophys; 2012 Aug; 49(4):228-35. PubMed ID: 23077783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments.
    Sugahara KN; Hirata T; Hayasaka H; Stern R; Murai T; Miyasaka M
    J Biol Chem; 2006 Mar; 281(9):5861-8. PubMed ID: 16407205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering.
    Yang C; Cao M; Liu H; He Y; Xu J; Du Y; Liu Y; Wang W; Cui L; Hu J; Gao F
    J Biol Chem; 2012 Dec; 287(51):43094-107. PubMed ID: 23118219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 expression indicates favorable prognosis in epithelial ovarian cancer.
    Sillanpää S; Anttila MA; Voutilainen K; Tammi RH; Tammi MI; Saarikoski SV; Kosma VM
    Clin Cancer Res; 2003 Nov; 9(14):5318-24. PubMed ID: 14614016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
    Gross N; Balmas K; Brognara CB
    Cancer Res; 1997 Apr; 57(7):1387-93. PubMed ID: 9102228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane.
    Saito T; Kawana H; Azuma K; Toyoda A; Fujita H; Kitagawa M; Harigaya K
    Int J Oncol; 2011 Nov; 39(5):1311-20. PubMed ID: 21743962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer.
    Lipponen P; Aaltomaa S; Tammi R; Tammi M; Agren U; Kosma VM
    Eur J Cancer; 2001 May; 37(7):849-56. PubMed ID: 11313172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.